Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Most common hereditary thrombophilia
Autosomal dominant inheritance pattern
Heterozygous form in 5% of white population in USA (up to 15% in Europe), 2% of Hispanic Americans, 1% in both African and Native Americans
Homozygosity in white population 1:5000
May account for 85–95% of pts with APC resistance
Relative risk of venous thrombosis sevenfold in heterozygous and 80-fold in homozygotes
VTE: DVT most likely; lower risk of PE
Risk of arterial thrombosis unknown
Hypercoagulability
DVT
Recurrent fetal loss (twofold to fivefold increased relative risk)
Conflicting data regarding association with placental abruption, severe preeclampsia, IUGR
Cerebral vein thrombosis
Renal transplant rejection
Risk of thrombosis increased by protein S deficiency, prothrombin 20210 gene mutation, hyperhomocysteinemia, OCP use, pregnancy, increasing age, immobilization, and obesity
Factor Va is a procoagulant that is inactivated by APC, with protein S as cofactor, causing less thrombin generation during the propagation phase.
FVL is resistant to inactivation by APC so thrombin generation is allowed to continue and subsequent clot formation.
FVL paradox describes the higher prevalence of FVL in pts with DVT compared with FVL pts with pulmonary embolism.
In CPB, FVL pts found to have less blood loss and need less blood transfusion during hospital stay.
Testing in FVL is the same as other causes of thrombophilia: Venous thrombosis and age <50 y; unusual sites of thrombosis (hepatic, mesenteric, cerebral); recurrent venous thrombosis; venous thrombosis with strong history of thrombotic disease, venous thrombosis in pregnant women taking oral contraceptives, relatives of pts who had venous thrombosis <50 y, MI in female smokers <50 y.
Screening test: Modified APC resistance functional assay (sensitivity and specificity for FVL close to 100%).
Confirmation test: DNA test. In liver transplant pts, DNA test positive, plasma FVL negative. In bone marrow transplant pts, DNA test negative, but plasma shows APC resistance.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here